TMS and CBT-I for comorbid depression and insomnia. Exploring feasibility and tolerability of transcranial magnetic stimulation (TMS) and cognitive behavioral therapy for insomnia (CBT-I) for comorbid major depressive disorder and insomnia during the COVID-19 pandemic.
Publication
, Journal Article
Norred, MA; Haselden, LC; Sahlem, GL; Wilkerson, AK; Short, EB; McTeague, LM; George, MS
Published in: Brain Stimul
2021
Duke Scholars
Altmetric Attention Stats
Dimensions Citation Stats
Published In
Brain Stimul
DOI
EISSN
1876-4754
Publication Date
2021
Volume
14
Issue
6
Start / End Page
1508 / 1510
Location
United States
Related Subject Headings
- Treatment Outcome
- Transcranial Magnetic Stimulation
- Sleep Initiation and Maintenance Disorders
- SARS-CoV-2
- Pandemics
- Neurology & Neurosurgery
- Humans
- Feasibility Studies
- Depressive Disorder, Major
- Depression
Citation
APA
Chicago
ICMJE
MLA
NLM
Norred, M. A., Haselden, L. C., Sahlem, G. L., Wilkerson, A. K., Short, E. B., McTeague, L. M., & George, M. S. (2021). TMS and CBT-I for comorbid depression and insomnia. Exploring feasibility and tolerability of transcranial magnetic stimulation (TMS) and cognitive behavioral therapy for insomnia (CBT-I) for comorbid major depressive disorder and insomnia during the COVID-19 pandemic. Brain Stimul, 14(6), 1508–1510. https://doi.org/10.1016/j.brs.2021.09.007
Norred, Michael A., Lindsay C. Haselden, Gregory L. Sahlem, Allison K. Wilkerson, E Baron Short, Lisa M. McTeague, and Mark S. George. “TMS and CBT-I for comorbid depression and insomnia. Exploring feasibility and tolerability of transcranial magnetic stimulation (TMS) and cognitive behavioral therapy for insomnia (CBT-I) for comorbid major depressive disorder and insomnia during the COVID-19 pandemic.” Brain Stimul 14, no. 6 (2021): 1508–10. https://doi.org/10.1016/j.brs.2021.09.007.
Norred MA, Haselden LC, Sahlem GL, Wilkerson AK, Short EB, McTeague LM, et al. TMS and CBT-I for comorbid depression and insomnia. Exploring feasibility and tolerability of transcranial magnetic stimulation (TMS) and cognitive behavioral therapy for insomnia (CBT-I) for comorbid major depressive disorder and insomnia during the COVID-19 pandemic. Brain Stimul. 2021;14(6):1508–10.
Norred, Michael A., et al. “TMS and CBT-I for comorbid depression and insomnia. Exploring feasibility and tolerability of transcranial magnetic stimulation (TMS) and cognitive behavioral therapy for insomnia (CBT-I) for comorbid major depressive disorder and insomnia during the COVID-19 pandemic.” Brain Stimul, vol. 14, no. 6, 2021, pp. 1508–10. Pubmed, doi:10.1016/j.brs.2021.09.007.
Norred MA, Haselden LC, Sahlem GL, Wilkerson AK, Short EB, McTeague LM, George MS. TMS and CBT-I for comorbid depression and insomnia. Exploring feasibility and tolerability of transcranial magnetic stimulation (TMS) and cognitive behavioral therapy for insomnia (CBT-I) for comorbid major depressive disorder and insomnia during the COVID-19 pandemic. Brain Stimul. 2021;14(6):1508–1510.
Published In
Brain Stimul
DOI
EISSN
1876-4754
Publication Date
2021
Volume
14
Issue
6
Start / End Page
1508 / 1510
Location
United States
Related Subject Headings
- Treatment Outcome
- Transcranial Magnetic Stimulation
- Sleep Initiation and Maintenance Disorders
- SARS-CoV-2
- Pandemics
- Neurology & Neurosurgery
- Humans
- Feasibility Studies
- Depressive Disorder, Major
- Depression